| # | Drug | Count |
|---|---|---|
| 0 | OBINUTUZUMAB | 8 |
| 1 | PREDNISONE | 7 |
| 2 | RITUXIMAB | 7 |
| 3 | BENDAMUSTINE HCL | 3 |
| 4 | CISPLATIN | 3 |
| 5 | CYCLOPHOSPHAMIDE | 3 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 8 | CYTARABINE | 3 |
| 9 | DEXAMETHASONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OBINUTUZUMAB | 8 | 0.0005 |
| 1 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 2 | BENDAMUSTINE HCL | 3 | 0.0002 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 4 | AMITRIPTYLINE HYDROCHLORIDE | 2 | 0.0001 |
| 5 | VINCRISTINE SULFATE | 3 | 0.0001 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 2 | 0.0001 |
| 7 | OFATUMUMAB | 2 | 0.0001 |
| 8 | CYTARABINE | 3 | 0.0000 |
| 9 | OCRELIZUMAB | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 11 | 0.0000 |
| 2 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 8 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 3 | 0.0000 |